EMERGING PATTERNS IN THE DIGITAL REVOLUTION OF THE PHARMACEUTICAL SECTOR

НОВЫЕ ТЕНДЕНЦИИ В ЦИФРОВОЙ РЕВОЛЮЦИИ ФАРМАЦЕВТИЧЕСКОЙ ОТРАСЛИ

Хазима МХД Ваел

студент магистратуры, кафедра бизнес-информатики, Национальный исследовательский университет ИТМО,

РФ, г. Санкт - Петербург

ABSTRACT

The primary objective of this article is to identify the key patterns in the digital revolution of the pharmaceutical sector, as these technologies will shape the progress of nations and pharmaceutical enterprises in the 21st century, guaranteeing their competitiveness and operational effectiveness.

АННОТАЦИЯ

Основная цель данной статьи заключается в выявлении основных тенденций цифровой революции в фармацевтической отрасли, поскольку эти технологии будут формировать прогресс наций и фармацевтических предприятий в 21 веке, гарантируя их конкурентоспособность и операционную эффективность.

Keywords: trends, pharmaceutical industry, technologies, production.

Ключевые слова: тренды, фармацевтическая промышленность, технологии, производство.

Introduction

Over the past 40 years, information technology has had a significant impact on the lives of millions of people, and various industries have begun to use these technologies due to the speed, accuracy, and promptness of information processing. This enables them to enhance the efficiency of their production activities through the automation of processes related to the execution of routine, repetitive, and monotonous tasks.

Information technology has also firmly established itself in the pharmaceutical industry. As information systems automate management, marketing, and logistics processes, they have a significant influence on the financial aspects of pharmaceutical companies' operations [1, p. 5].

Digital transformation in the pharmaceutical sector offers ways to review existing business models, improve production processes, and enhance the pharmacy's responsiveness to the challenges that currently shape civilization's development. These challenges include increasing volumes of information exchange and the emergence of new diseases, as well as improving the accessibility of pharmaceutical products [2, p. 5].

Thus, the aim of this article is to identify the key trends of digital transformation in the pharmaceutical industry.

1) Pharma 4.0. Systematic research aimed at defining the key trends of digital transformation in the pharmaceutical industry shows that by the end of the first third of the 21st century, the global pharmaceutical industry responded with a sufficient degree of completeness (and quite rapidly) to the Fourth Industrial Revolution (Industry 4.0). The result was an emphasis on new approaches to production (which is already based on the widespread implementation of information technology in the industry), massive automation of business processes, and active integration of artificial intelligence into all areas of management and the economy.

The global pharmaceutical industry's response to the development of "Industry 4.0" was most concentrated in the creation of its own strategic development concept called "Pharma 4.0".

The idea is to transition from the current strategy of managing pharmaceutical production, which is based on "stage-based management" of production activities using various management concepts (development, production, logistics, marketing, etc.), to a holistic strategy that includes process automation throughout the entire product lifecycle. Overall, the main goal of Pharma 4.0 is to make pharmaceutical production safer and more efficient across the entire value chain [3, p. 5].

2) The Internet of Things (IoT) is a system for tracking information about the "behavior" of physical objects (material things) through installed sensors. Alongside IoT sensors, it involves the development of corresponding software that enables remote monitoring through internet connectivity. Thus, this technology "makes things smart" by exchanging information with similar connected components. As indicated, the Internet of Things can help pharmaceutical organizations enhance the quality of pharmaceutical products by ensuring continuous monitoring of production technologies, reducing logistics costs, and enabling complete digitization of information within pharmaceutical companies. Thanks to the constant availability of information, pharmaceutical organizations can guarantee the appropriate quality and information transparency to consumers [4, p. 5].

3) Blockchain is a systematically organized information chain in which each subsequent information block contains all the information created earlier and stored in the previous block. Any unauthorized attempt to introduce information into this system is automatically rejected because it does not belong to the "information field" of the previous block. These capabilities enhance the quality of information protection, and the potential applications of blockchain are already actively utilized by advanced pharmaceutical companies, including in the fight against the production and distribution of counterfeit products. Blockchain-based digital systems ensure supply chain control by tracking each stage of the chain at the level of individual medicinal products.

4) Cloud technologies. Currently, the scalability and flexibility of the "cloud" can help pharmaceutical companies of any size optimize clinical trials and reduce costs while enabling business growth and expansion. These technologies can also be an ideal solution for research and development, helping process vast amounts of data that companies deal with in R&D activities.

5) Artificial intelligence. Currently, the use of artificial intelligence is regarded by global manufacturers as the most valuable element of digital transformation. This digitization tool is used for creating new medications based on the development of appropriate formulas, predicting the effects of untested components on the human body, modeling immune system cell reactions to vaccine administration, analytically processing information about compounds used in drug development, and reducing the duration of drug trials.

Conclusion

The article has examined the key trends of digital transformation in the pharmaceutical industry that will shape its development in the 21st century and ultimately determine the success of countries and companies in the global pharmaceutical market. This success is contingent upon the effective implementation of the Pharma 4.0 concept, artificial intelligence technologies, blockchain, and cloud computing.

References:

1. Goundry-Smith St. Studying the role of new technologies in pharmacy: now and in the future. Pharmaceutical Journal, February 2014. URL: https://pharmaceutical-journal.com/article/news/examining-the-role-of-new-technology-in-pharmacy-now-and-in-the-future (date of the application 24.06.2023)
2. Sandl T. Digital transformation of pharmaceuticals and healthcare. IVT Network, 2019. URL: https://bioprocessintl.com/manufacturing/information-technology/digital-transformation-in-biopharmaceutical-operations/ (date of the application 25.06.2023)
3. Markarian J. Pharma 4.0 Pharmaceutic al Technology, Pharmaceutical Technology, 2018, V. 42, Issue 4. 24 р.
4. Singh M., Sachan S., Singh A. Internet of Things in the pharmaceutical industry: opportunities and problems. The emergence of the Growth of the pharmaceutical industry using an industrial IoT approach. 2020, p. 195-216. URL:https://www.sciencedirect.com/science/article/abs/pii/B9780128195932000078 (date of the application 24.06.2023)